Fulgent Genetics (FLGT) Non-Current Debt (2021 - 2025)
Fulgent Genetics (FLGT) has disclosed Non-Current Debt for 5 consecutive years, with $2.0 million as the latest value for Q4 2025.
- Quarterly Non-Current Debt fell 21.46% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Dec 2025, down 21.46% year-over-year, with the annual reading at $2.0 million for FY2025, 21.46% down from the prior year.
- Non-Current Debt hit $2.0 million in Q4 2025 for Fulgent Genetics, roughly flat from $2.0 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $5.9 million in Q3 2021 to a low of $2.0 million in Q1 2025.
- Historically, Non-Current Debt has averaged $3.0 million across 5 years, with a median of $2.5 million in 2024.
- Biggest five-year swings in Non-Current Debt: dropped 12.1% in 2023 and later fell 21.46% in 2025.
- Year by year, Non-Current Debt stood at $5.9 million in 2021, then plummeted by 43.3% to $3.4 million in 2022, then decreased by 12.1% to $3.0 million in 2023, then dropped by 15.89% to $2.5 million in 2024, then dropped by 21.46% to $2.0 million in 2025.
- Business Quant data shows Non-Current Debt for FLGT at $2.0 million in Q4 2025, $2.0 million in Q3 2025, and $2.0 million in Q2 2025.